Literature DB >> 19869638

ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA.

F T Lord1, G E Nesche.   

Abstract

1. Protective substances and agglutinins were not demonstrated in the blood of patients with pneumonia untreated with serum before the fall in the temperature by crisis or lysis. 2. Protective substances and agglutinins were frequently demonstrated in serum treated patients during the course of the disease. 3. Protective substances and agglutinins were usually present at the time of the temperature fall in patients untreated with serum and persisted for days or weeks thereafter. 4. Protective substances have an important bearing on the outcome. A large proportion of those with protection recover and a large proportion without it die. 5. Agglutinin and antibody may appear simultaneously or one may precede or be present without the other. 6. Tests for agglutinin are unreliable as a control of dosage of specific serum.

Entities:  

Year:  1929        PMID: 19869638      PMCID: PMC2131646          DOI: 10.1084/jem.50.4.449

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  CERTAIN ASPECTS OF MOUSE PROTECTION TESTS FOR ANTIBODY IN PNEUMOCOCCUS PNEUMONIA.

Authors:  F T Lord; E L Persons
Journal:  J Exp Med       Date:  1931-01-31       Impact factor: 14.307

2.  CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE.

Authors:  T Francis; W S Tillett
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.